河南中医药大学,河南省郑州市金水东路156号,450046
zhengxk.2006@163.com
收稿:2022-03-05,
修回:2022-11-19,
纸质出版:2023-02-02
移动端阅览
张贝贝,曾梦楠,王亚玺等.基于“顺病位逆病势”的麻黄升浮药性和葶苈子沉降药性潜在靶点研究[J].中医杂志,2023,64(03):303-310.
ZHANG Beibei,ZENG Mengnan,WANG Yaxi,et al.Study on Potential Targets for the Ascending and Floating Nature of Mahuang(Herba Ephedrae)and Descending and Sinking Nature of Tinglizi (Semen Descurainiae seu Lepidii) based on “Conforming to the Location of the Disease and Reversing the Tendency of the Disease”[J].Journal of Traditional Chinese Medicine,2023,64(03):303-310.
张贝贝,曾梦楠,王亚玺等.基于“顺病位逆病势”的麻黄升浮药性和葶苈子沉降药性潜在靶点研究[J].中医杂志,2023,64(03):303-310. DOI: 10.13288/j.11-2166/r.2023.03.015.
ZHANG Beibei,ZENG Mengnan,WANG Yaxi,et al.Study on Potential Targets for the Ascending and Floating Nature of Mahuang(Herba Ephedrae)and Descending and Sinking Nature of Tinglizi (Semen Descurainiae seu Lepidii) based on “Conforming to the Location of the Disease and Reversing the Tendency of the Disease”[J].Journal of Traditional Chinese Medicine,2023,64(03):303-310. DOI: 10.13288/j.11-2166/r.2023.03.015.
目的
2
探究麻黄升浮药性和葶苈子沉降药性的潜在靶点。
方法
2
将340只大鼠采用随机数字表法分为风寒表证模型组80只、风水水肿模型组90只、痰饮停聚模型组90只、肺水模型组80只,各组大鼠按体质量均衡原则及造模需要再行分组。采用吹风加寒冷刺激构建大鼠风寒表证模型,分为正常对照组、风寒表证组、麻黄组、生物碱组、多糖组、非生物碱组和通宣理肺丸组7组,各组均连续灌胃4天;采用尾静脉注射盐酸多柔比星联合吹风刺激构建大鼠风水水肿模型,分为正常对照组、风水水肿组、麻黄组、生物碱组、多糖组、非生物碱组和通宣理肺丸组7组,各组均连续灌胃21天;采用腹腔注射卵白蛋白联合雾化激发构建大鼠痰饮停聚模型,分为正常对照组、痰饮停聚组、葶苈子组、黄酮苷组、黄酮苷元组、低聚糖组、多糖组和脂肪油组8组,各组均连续灌胃7天;通过胸腔注射角叉菜胶构建大鼠肺水模型,分为正常对照组、肺水组、葶苈子组、黄酮苷组、黄酮苷元组、低聚糖组、多糖组和脂肪油组8组,各组均连续灌胃7天。灌胃完成后检测各模型毒蕈碱乙酰胆碱受体M3(CHRM3)、毒蕈碱乙酰胆碱受体M1(CHRM1)和过氧化物酶体增殖物激活受体γ(PPAR-γ)的mRNA水平;检测风寒表证和风水水肿模型CHRM3的蛋白表达,痰饮停聚和肺水模型PPAR-γ的蛋白表达。
结果
2
与风寒表证组相比,麻黄组、通宣理肺丸组和生物碱组CHRM3的蛋白及mRNA水平,麻黄组CHRM1的mRNA水平显著升高,非生物碱组CHRM3,通宣理肺丸组和非生物碱组CHRM1及麻黄组、通宣理肺丸组、生物碱组和多糖组PPAR-γ的mRNA水平显著降低(
P
<0.05或
P
<0.01)。与风水水肿组相比,麻黄组、通宣理肺丸组和生物碱组CHRM3的蛋白及mRNA水平,麻黄组和通宣理肺丸组CHRM1的mRNA水平,通宣理肺丸组、生物碱组、非生物碱组和多糖组PPAR-γ的mRNA水平显著升高,麻黄组PPAR-γ的mRNA水平显著降低(
P
<0.05或
P
<0.01)。与痰饮停聚组相比,低聚糖组CHRM3的mRNA水平,葶苈子组、低聚糖组、黄酮苷组和脂肪油组PPAR-γ的蛋白及mRNA水平显著升高,脂肪油组和黄酮苷元组CHRM1的mRNA水平显著降低(
P
<0.01)。与肺水组相比,葶苈子组CHRM3的mRNA水平、多糖组PPAR-γ的mRNA水平显著降低,低聚糖组、脂肪油组和多糖组CHRM3的mRNA水平,葶苈子组、黄酮苷组、低聚糖组和脂肪油组PPAR-γ的蛋白及mRNA水平,多糖组和黄酮苷元组CHRM1的mRNA水平显著升高(
P
<0.05或
P
<0.01)。
结论
2
药性升浮的麻黄及生物碱组分和通宣理肺丸可显著促进病位在表的风寒表证和风水水肿模型大鼠CHRM3的表达,其可能为麻黄升浮药性的潜在作用靶点之一;药性沉降的葶苈子、黄酮苷、低聚糖和脂肪油可显著促进病位在里的痰饮停聚和肺水模型大鼠PPAR-γ的表达,其可能为葶苈子沉降药性的潜在作用靶点之一。
Objective
2
To Explore the potential targets of the ascending and floating nature of Mahuang (
Herba Ephedrae
) as well as the descending and sinking nature of Tinglizi (
Semen Descurainiae seu Lepidii
).
Methods
2
Totally 340 rats were randomly divided into wind-cold exterior pattern model group (n=80), wind-water edema model group (n=90), phlegm-rheum retention model group (n=90), and pulmonary edema model group (n=80). Further grouping was performed according to the principle of weight balance and modeling needs. The model of wind-cold exterior pattern was constructed by blowing wind and cold stimulation, and the rats were further divided into normal control group, wind-cold exterior pattern group, Mahuang group, alkaloid group, polysaccharide group, non-alkaloid group and
Tongxuan Lifei Pill
(通宣理肺丸) group. All groups were given continous gavage for four days. The wind-water edema rat model was established by tail vein injection of adriamycin plus blowing wind, and the rats were divided into normal control, wind-water edema, Mahuang, alkaloid, polysaccharide, non-alkaloid and
Tongxuan Lifei Pill
groups, which were all administered with continuous gavage for 21 days. The phlegm-rheum retention rat model was established through intraperitoneal injection of ovalbumin and with atomization, and the modeled rats were divided into normal control, phlegm-rheum retention, Tinglizi, flavonoid glycoside, flavonoid aglycones, oligosaccharide, polysaccharide and fatty oil groups, which were all given intragastric administration continuously for 7 days. The pulmonary edema model was established by pleural injection of carrageenan, and the rats were divided into normal control, pulmonary edema, Tinglizi, flavonoid glycoside, flavonoid aglycones, oligosaccharide polysaccharide and fatty oil groups, all for 7 days of intragastric administration continuously. The mRNA levels of muscarinic acetylcholine receptor M3 (CHRM3), muscarinic acetylcholine receptor M1 (CHRM1) and peroxisome proliferator-activated receptor γ (PPAR-γ) were detected. The protein expression of CHRM3 in wind-cold exterior pattern and wind-water edema model, and the protein expression of PPAR-γ in phlegm-rheum retention and pulmonary edema model were detected.
Results
2
Compared to those in the wind-cold exterior pattern group, the protein and mRNA level of CHRM3 in the Mahuang,
Tongxuan Lifei Pill
and alkaloid groups, as well as the mRNA level of CHRM1 in the Mahuang group significantly increased, while the level of CHRM3 in the non-alkaloid group, the CHRM1 level in the
Tongxuan Lifei Pill
and non-alkaloid groups, and the mRNA level of PPAR-γ in the Mahuang,
Tongxuan Lifei Pill
, alkaloid and polysaccharide groups significantly decreased (
P
<0.01 or
P
<0.05). Compared to those in the wind-water edema group, the protein and mRNA level of CHRM3 in the Mahuang,
Tongxuan Lifei Pill
and
alkaloid groups, the mRNA level of CHRM1 in the Mahuang and
Tongxuan Lifei Pill
groups, as well as the mRNA level of PPAR-γ in the
Tongxuan Lifei Pill,
alkaloid, non-alkaloid and polysaccharide groups significantly increased, while the mRNA level of PPAR-γ in the Mahuang group significantly decreased (
P
<0.01 or
P
<0.05). Compared to those in the phlegm-rheum retention group, the mRNA level of CHRM3 in the oligosaccharide group, and the protein and mRNA level of PPAR-γ in the Tinglizi, oligosaccharide group, flavonoid glycoside group and fatty oil group significantly increased, while the mRNA level of CHRM1 in the fatty oil group and flavonoid aglycon group were reduced (
P
<0.01). Compared to those in the pulmonary edema group, the mRNA level of CHRM3 in the Tinglizi group, and the mRNA level of PPAR-γ in the polysaccharide group were significantly reduced, while the mRNA level of CHRM3 in the oligosaccharide group, fatty oil group and polysaccharide group, the mRNA level of PPAR-γ in the Tinglizi group, flavonoid glycoside group, oligosaccharide group and fatty oil group, and the mRNA level of CHRM1 in the polysaccharide group and flavonoid aglycon group increased (
P
<0.01 or
P
<0.05).
Conclusion
2
Mahuang of ascending and floating nature, alkaloid and
Tongxuan Lifei Pill
could increase the expression of CHRM3 in the rats model of wind-cold exterior pattern and wind-water edema where the disease is located at the exterior; CHRM3 may be one of the potential targets of the ascending and floating nature of Mahuang. Tinglizi of descending and sinking nature, oligosaccharide, flavonoid glycoside and fatty oil could increase the level of PPAR-γ in the model of phlegm-rheum retention and pulmonary edema where the disease is located at the interior; PPAR-γ may be one of the potential targets of descending and sinking nature of Tinglizi.
陈勇 , 杨敏 , 闵志强 , 等 . 析中药升降浮沉渊源流变 [J]. 四川中医 , 2016 , 34 ( 10 ): 17 - 20 .
钟赣生 . 中药学 [M]. 北京 : 中国中医药出版社 , 2021 : 27 - 28 .
傅阳 , 袁培培 , 侯颖 , 等 . 基于GnRHR信号通路探讨升浮药麻黄与沉降药葶苈子干预哮喘作用差异 [J]. 中华中医药杂志 , 2022 , 37 ( 5 ): 2553 - 2562 .
项丽玲 , 李艳 , 苗明三 . 升降浮沉药性现代药理研究的分析与思考 [J]. 中华中医药杂志 , 2019 , 34 ( 11 ): 5269 - 5272 .
张贝贝 , 曾梦楠 , 王亚玺 , 等 . 典型升浮中药和沉降中药潜在作用靶点网络药理学及大鼠体内验证研究 [J]. 中医杂志 , 2023 , 64 ( 2 ): 174 - 181 .
曹艳梅 , 张囡 , 史楠楠 , 等 . 基于古代经方传承的清肺排毒汤组方配伍分析 [J]. 世界中医药 , 2022 , 17 ( 9 ): 1343 - 1349 .
李苗 , 曾梦楠 , 张贝贝 , 等 . 麻黄水煎液及拆分组分对肾阳虚水肿大鼠的影响 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 23 ): 91 - 96 .
徐瑞齐 . 基于“风水水肿”模型的麻黄拆分组分升降浮沉药性研究 [D]. 郑州 : 河南中医药大学 , 2022 .
吴媛媛 . 基于“风寒表证”动物模型的麻黄拆分组分升降浮沉药性研究 [D]. 郑州 : 河南中医药大学 , 2022 .
刘庆林 . 葶苈子药对的临床应用 [J]. 光明中医 , 2006 , 21 ( 12 ): 58 - 59 .
袁培培 , 侯颖 , 李潘莹 , 等 . 基于痰饮停聚哮喘模型及主成分分析的葶苈子化学拆分组分沉降药性归属研究 [J]. 中草药 , 2022 , 53 ( 2 ): 449 - 460 .
杨士友 , 孙备 , 裴月梅 , 等 . 风寒表证和寒凝血瘀证动物模型的研究 [J]. 中国中医基础医学杂志 , 1997 , 3 ( 1 ): 54 - 64 .
曹兵 . 基于“风寒表证”模型的麻黄升降浮沉药性研究 [D]. 郑州 : 河南中医药大学 , 2021 .
魏伟 . 药理实验方法学 [M]. 北京 : 人民卫生出版社 , 2010 : 71 .
蔺建军 , 杨勇 , 高娜 , 等 . 阿霉素注射次数及剂量对肾病综合征模型的影响 [J]. 中国中西医结合肾病杂志 , 2011 , 12 ( 8 ): 676 - 678,755 .
赵彧 , 杜志仙 . 阿霉素致肾阳虚水肿模型大鼠三种实验方法的对比研究 [J]. 山东中医杂志 , 2011 , 30 ( 3 ): 190 - 193 .
张仲景 . 金匮要略 [M]. 北京 : 人民卫生出版社 , 2012 : 56 - 58 .
李本科 . 基于“风水水肿”模型的麻黄升浮药性研究 [D]. 郑州 : 河南中医药大学 , 2021 .
娄慧慧 , 唐迎雪 , 梁晓东 , 等 . 支气管哮喘肺阳虚证及其动物模型研究概况 [J]. 山东中医药大学学报 , 2022 , 46 ( 5 ): 662 - 665 .
李平 , 卢韵碧 , 周汉良 , 等 . 大鼠角叉菜胶胸膜炎渗出白细胞磷脂酶D活性的变化 [J]. 中国药理学通报 , 2000 , 16 ( 1 ): 39 - 43 .
邓慧 , 闫玲玲 , 王健 . 从升降浮沉药性理论探析升阳益胃汤立方本旨 [J]. 亚太传统医药 , 2021 , 17 ( 5 ): 107 - 109 .
陈龙 . 浅析中药升降浮沉药性理论 [J]. 广西中医药 , 2020 , 43 ( 2 ): 44 - 47 .
丛馨 , 闵赛南 , 吴立玲 , 等 . 激活毒蕈碱乙酰胆碱受体调控下颌下腺分泌的机制研究 [J]. 北京大学学报(医学版) , 2019 , 51 ( 3 ): 390 - 396 .
陈超 , 张瑞芬 , 张海荣 . PPAR-γ与动脉粥样硬化及其危险因素的相关研究进展 [J]. 中国循证心血管医学杂志 , 2021 , 13 ( 9 ): 1146 - 1147 .
王贵佐 , 卢家美 , 谢新明 , 等 . 过氧化物酶体增殖物激活受体在肺部疾病中的作用 [J]. 中国药理学通报 , 2013 , 29 ( 1 ): 18 - 22 .
0
浏览量
2
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号